Jill W. Ruppenkamp, MSc
Articles
March 4th 2024
Insurer Costs of COVID-19 by Disease Severity and Duration
Chantal E. Holy, PhD, MSc Brandon J. Patterson, PhD Jill W. Ruppenkamp, MSc Fayolah Richards, PharmD Ronita Debnath, BSc Antoine C. El Khoury, PhD Jessica K. DeMartino, PhD Brahim Bookhart, MBA, MPH Paul M. Coplan, PhD, MBA
Payer costs for COVID-19 ranged from a mean of $505 for asymptomatic cases to $126,094 for severe cases with post–COVID-19 condition.
October 12th 2023
Health Care Costs of COVID-19 vs Influenza and Pneumonia
Fayolah Richards, PharmD Brandon J. Patterson, PhD Jill W. Ruppenkamp, MSc Ronita Debnath, BSc Antoine C. El Khoury, PhD Jessica K. DeMartino, PhD Brahim Bookhart, MBA, MPH Chantal E. Holy, PhD, MSc Paul M. Coplan, PhD, MBA
COVID-19 health care costs are significantly greater than those for influenza and pneumonia. Treatment costs for severe COVID-19 exceed those for influenza and pneumonia by approximately $50,000.
Latest Updated Articles
Published: November 15th 2024 | Updated: November 19th 2024
FDA Approves Revumenib for R/R Acute Leukemia With a KMT2A Translocation
Published: April 1st 2024 | Updated: November 5th 2024
What We're Reading: Concierge Nonprofit Hospitals; Kaiser Permanente Elderly Care Program; Health Care Not Among Top Voter Issues
Published: October 21st 2024 | Updated: October 24th 2024
Lower Diagnostic Error Rates Found Among Hospitalized Patients During Care Transitions
Published: September 26th 2024 | Updated: October 1st 2024
Addressing Natural Disaster Takes Cooperation, Preparation to Ensure Patient Health
Published: May 9th 2024 | Updated: May 21st 2024
FDA Accepts Nivolumab Subcutaneous Injection Application, With Potential to Boost Access to PD-1 Inhibitors
Published: December 17th 2024 | Updated: December 21st 2024
ICYMI: Highlights From IMS 2024
